Category: l04aa23
Natalizumab - TYSABRI 300 mg, solution à diluer pour perfusion
Natalizumab TYSABRI 300 mg, solution à diluer pour perfusion - L04AA23 BIOGEN IDEC LIMITED (RO
View DetailsFind the best businesses and services near you. Discover verified companies across all industries.
Natalizumab TYSABRI 300 mg, solution à diluer pour perfusion - L04AA23 BIOGEN IDEC LIMITED (RO
View Details